LAS-R HUMAN C1 ESTERASE INHIBITOR TEST— 510(k) K780335

Substantially Equivalent

Hyland Therapeutic Div., Travenol Laboratories

FDA 510(k) clearance K780335 for LAS-R HUMAN C1 ESTERASE INHIBITOR TEST, Substantially Equivalent on 1978-03-22. Applicant: Hyland Therapeutic Div., Travenol Laboratories.

Clearance details

Applicant
Hyland Therapeutic Div., Travenol Laboratories
Product code
Code DBA
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mchenry, IL, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.